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Atrophy is a defining feature of aging skeletal muscle that contributes to progressive
weakness and an increased risk of mobility impairment, falls, and physical frailty in very
advanced age. Amongst the most frequently implicated mechanisms of aging muscle atro-
phy is mitochondrial dysfunction. Recent studies employing methods that are well-suited to
interrogating intrinsic mitochondrial function find that mitochondrial respiration and reactive
oxygen species emission changes are inconsistent between aging rat muscles undergoing
atrophy and appear normal in human skeletal muscle from septuagenarian physically active
subjects. On the other hand, a sensitization to permeability transition seems to be a general
property of atrophying muscle with aging and this effect is even seen in atrophying mus-
cle from physically active septuagenarian subjects. In addition to this intrinsic alteration in
mitochondrial function, factors extrinsic to the mitochondria may also modulate mitochon-
drial function in aging muscle. In particular, recent evidence implicates oxidative stress in
the aging milieu as a factor that depresses respiratory function in vivo (an effect that is not
present ex vivo). Furthermore, in very advanced age, not only does muscle atrophy become
more severe and clinically relevant in terms of its impact, but also there is evidence that
this is driven by an accumulation of severely atrophied denervated myofibers. As denerva-
tion can itself modulate mitochondrial function and recruit mitochondrial-mediated atrophy
pathways, future investigations need to address the degree to which skeletal muscle mito-
chondrial alterations in very advanced age are a consequence of denervation, rather than a
primary organelle defect, to refine our understanding of the relevance of mitochondria as
a therapeutic target at this more advanced age.
Keywords: sarcopenia, bioenergetics, mitochondria, skeletal muscle, reactive oxygen species, permeability transi-
tion, oxidative stress, muscle atrophy
INTRODUCTION
Progressive atrophy is a defining feature of aging skeletal mus-
cle and when it becomes severe in very advanced age (≥80 years of
age), it can lead to weakness that precipitates mobility impairment,
an increased risk of falls, and physically frailty (Cruz-Jentoft et al.,
2010). For this reason, understanding the mechanisms underlying
aging muscle atrophy so that suitable therapeutic targets can be
identified is key to promoting health and mobility in the elderly.
Whilst many possible targets have been suggested, the most effec-
tive therapeutic targets will be those that serve as a nexus point for
modulating a wide range of cellular functions that are affected with
aging; a concept that brings to mind the role of the mitochondrion.
Mitochondria serve a central role as an integrator of a variety
of signals within the cell, and accordingly vary their function to
modulate energy supply, reactive oxygen species (ROS) signaling,
and intrinsic pathways of apoptosis (Figure 1). For this reason,
mitochondria have been frequently studied as a target for combat-
ing cellular aging. This is also true of muscle cells where one of
the first studies to suggest impaired mitochondrial function may
be involved in muscle aging was performed in flies and poignantly
found that mitochondrial dysfunction was associated with loss of
the wings (Rockstein and Brandt, 1963)! A great many studies have
followed and although a substantial number have found evidence
for impaired mitochondrial function in aging muscle (Rumsey
et al., 1987; Trounce et al., 1989; Cooper et al., 1992; Conley et al.,
2000; Gouspillou et al., 2010, 2014a,b; Picard et al., 2011a), others
have not (Kent-Braun and Ng, 2000; Rasmussen et al., 2003; Lanza
et al., 2005), underscoring the complexity of understanding in this
area. The purpose of this review, therefore, is to address the basis
for these complexities, identify relevant mechanisms therein, and
finally to provide some suggestions for future investigation.
ADDRESSING THE QUESTION OF MITOCHONDRIAL
DYSFUNCTION IN AGING MUSCLE
There are numerous issues that need to be considered when evalu-
ating the involvement of mitochondria in aging of skeletal muscle.
The first issue to consider is the means by which the mitochon-
drial function is interrogated. For example, direct interrogation
of mitochondrial function frequently employs mechanical isola-
tion of mitochondria, a method that itself can induce alterations
in the intrinsic function of the organelle (Picard et al., 2011c).
Indeed, mechanical isolation of mitochondria not only exagger-
ates the magnitude of age-related impairment in various aspects
of mitochondrial function but also induces changes not seen in
a preparation where mitochondrial structure is preserved (Picard
et al., 2010).
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FIGURE 1 | Mitochondria respond to a wide array of intracellular signals
and accordingly modulate their function [ATP production, reactive
oxygen species (ROS) production, and sensitivity to permeability
transition] across a large dynamic range to meet the cellular needs. It
is thus important to understand whether alterations observed in aging
muscle represent a primary organelle defect versus a secondary (potentially
adaptive) response to a changing cellular environment.
A second issue to consider is which functional outputs are quan-
tified as it relates to the different roles that mitochondria serve in
skeletal muscle, including energy provision (respiration), signaling
(ROS emission), and regulation of apoptosis (e.g., through perme-
ability transition and release of mitochondrial-derived apoptotic
factors) (Picard et al., 2011a). Further to this point, it is also
essential to account for the fact that some mitochondrial func-
tional properties vary between fast twitch and slow twitch muscles
(Picard et al., 2012). For example, slow twitch muscles generally
exhibit lower mitochondrial ROS emission (Anderson and Neufer,
2006; Picard et al., 2008) and a lower capacity for calcium retention
before permeability transition occurs (Picard et al., 2008) when
compared to fast twitch muscles. Thus, in situations where muscle
exhibits a shift in fiber type with aging, the impact of this shift on
the mitochondrial function properties needs to be considered.
The third issue to consider is the age studied and in this respect,
it is important to address mitochondrial function across the aging
continuum, including study of ages that are most affected by the
consequences of aging muscle atrophy. As noted in the section
“Introduction,” this is typically ≥80 years of age (Cruz-Jentoft
et al., 2010) and thus far there is very little known about muscle
mitochondrial alterations in this age group from human studies,
although several studies in the animal literature exist (Chabi et al.,
2008; Ljubicic et al., 2009; Joseph et al., 2010; Picard et al., 2011a).
Related to this point, when using an animal model system the
age studied should represent points along the trajectory of muscle
aging that are relevant for human muscle.
A fourth issue to consider is that of physical activity because
it is well-established that skeletal muscle mitochondrial content
is highly adaptable and not only increases in response to elevated
metabolic demand but also decreases in response to reduced meta-
bolic demand, with the latter being the typical situation in aging
(Martin et al., 2014). As such, understanding the degree to which
mitochondrial content and functional alterations are an obligatory
consequence of aging versus being wholly or partially avoidable
through a physically active lifestyle, is of critical importance.
Finally, since mitochondria serve as central integrators of a
wide variety of cellular signals and thus exhibit a wide range of
what should be considered physiological (rather than pathologi-
cal) function (Picard et al., 2011b), it is essential to consider the
involvement of cellular alterations that are extrinsic to the mito-
chondria as modulating factors in their function before concluding
that a primary mitochondrial defect exists. For example, aging in
muscle has long been known to induce neurological alterations
such as neuromuscular junction instability leading to denerva-
tion (Tomonaga, 1977; Oda, 1984; Edstrom et al., 2007; Rudolf
et al., 2014), and these changes may themselves exert an impact on
the cellular environment that modulates mitochondrial function
(Csukly et al., 2006; Muller et al., 2007; Bhattacharya et al., 2009).
The suitability of the mitochondrion as a primary therapeutic tar-
get in this scenario needs to be carefully considered as reversing
mitochondrial alterations that are secondary to denervation [e.g.,
those that result in activation of atrophy pathways (Romanello
et al., 2010; Rowan et al., 2012)] could make the situation worse
rather than better by preventing atrophy of denervated fibers and
thereby increasing the burden on the remaining muscle fibers.
These issues will be addressed in detail in the sections that follow
to inform our current understanding of the role played by mito-
chondrial dysfunction in aging muscle atrophy and the resulting
implications for intervening at this level.
METHODS FOR EVALUATING MITOCHONDRIAL FUNCTION
Many different methodological approaches have been taken to
evaluate mitochondrial function in aging muscle, including direct
measures (e.g., isolated mitochondria, permeabilized myofibers)
and indirect measures [e.g.,phosphocreatine (PCr) recovery kinet-
ics following muscle contractions, enzyme assays, protein content,
etc.]. Similarly, a variety of functional outputs of mitochondria
have been examined, with indices related to mitochondrial res-
piration being by far the most frequent and measures of ROS
emission second most frequent, whereas to date there are relatively
few studies examining mitochondrial sensitivity to an apoptotic
challenge, particularly in the human literature. Importantly, the
impact of aging on the different aspects of mitochondrial func-
tion is often quite variable from one function to the next and this
has implications for understanding the involvement of mitochon-
dria in aging muscle. For example, a reduced respiratory capacity
could impact muscle fatigue by limiting energy provision to the
myocyte (Stary et al., 2004; Chabi et al., 2008), an increase in ROS
emission could induce cellular and organelle oxidative stress and
thereby increase the requirement for removal of resulting damage
(Fulle et al., 2004; Mansouri et al., 2006), and an increased sus-
ceptibility to permeability transition could increase the release of
mitochondrial-localized apoptotic factors thereby contributing to
nuclear loss and myocyte atrophy (Marzetti et al., 2010; Gouspillou
et al., 2014b).
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MITOCHONDRIAL ENZYME ACTIVITIES
By far the most common approach to gaining insights about mito-
chondrial function in aging muscle is the use of enzymatic assays of
representative mitochondrial enzymes, such as citrate synthase and
electron transport chain complexes, and these measures provide
indirect insights into the energy producing (respiratory) capacity
of the mitochondria. Most of the studies performed to date indi-
cate a marked decline in mitochondrial enzyme activities from
aging muscle (Bass et al., 1975; Lezza et al., 1994; Desai et al.,
1996; Hagen et al., 2004), although some studies find this to be
maintained (Orlander et al., 1978; Barrientos et al., 1996) and
others report it to be highly variable from one muscle to the next
(Houmard et al., 1998; Lyons et al., 2006). Importantly, individual
enzyme activities do not provide unambiguous insights about the
respiratory function of the intact mitochondrion because indi-
vidual enzyme activities can become very disparately related to
whole organelle function when the mitochondrion becomes defec-
tive. Thus, more direct and integrated measures of function are
required to interpret aging impact.
MECHANICALLY ISOLATED MITOCHONDRIA VERSUS
SAPONIN-PERMEABILIZED MYOCYTES
Amongst the most frequently used methodological approaches to
directly interrogate mitochondrial function involves the mechan-
ical isolation of mitochondria (Chance and Williams, 1956).
Although this method has been very widely used in the aging lit-
erature (Trounce et al., 1989; Boffoli et al., 1994; Capel et al., 2005;
Chabi et al., 2008; Gouspillou et al., 2010), as we have recently
reviewed (Picard et al., 2011b), not only does mechanical isola-
tion markedly disrupt the normal architecture of skeletal muscle
mitochondria from an irregular tubular network into smaller, rel-
atively homogenous, spherical structures, but it also profoundly
potentiates both mitochondrial ROS emission and sensitivity to
permeability transition (Figure 2). The importance of this to stud-
ies in aging is illustrated by the fact that when we compared the
apparent effect of aging on mitochondrial function in mitochon-
dria isolated from skeletal muscle versus saponin-permeabilized
myofibers (where mitochondrial structure is preserved) in very
old rat muscle (35% survival rate, which is a similar relative age
to ≥80 years old humans), we found the isolated mitochondria
profoundly exaggerated the impact of aging (Picard et al., 2010).
Specifically, with aging the decline in maximal mitochondrial
respiratory capacity was fourfold greater, the increase in ROS emis-
sion was twofold greater and the reduction in time to permeability
transition was twofold greater when examined in isolated mito-
chondria versus saponin-permeabilized myofibers (Figure 3). Not
only this, but there were significant alterations in mitochondrial
enzyme activity stoichiometry (reduced ratio of cytochrome oxi-
dase to citrate synthase activity) and stoichiometry of respiratory
states (suggestive of a defect in complex I) in isolated mito-
chondria with aging that were not seen in saponin-permeabilized
myofibers. We have suggested that these latter observations may be
indicative of a lesser ability of aged mitochondria to reseal during
isolation procedures, since isolation induces transient disruption
of tubular mitochondrial structures and subsequent reconstitu-
tion into the spherical organelles typical of isolates, resulting
in greater contamination and/or loss of mitochondrial matrix
FIGURE 2 | Multiple features of mitochondrial structure and function
are altered in mechanically isolated organelles compared to
saponin-permeabilized myofibers (representing a preparation where
all mitochondria are represented and their structure remains intact). In
particular, the irregular tubular structure is lost following isolation, producing
more homogenous spherical structures. Accompanying these structural
changes is a marked potentiation of reactive oxygen species (ROS)
emission and sensitization to mitochondrial permeability transition pore
(mPTP) opening. Data are re-plotted from Picard et al. (2011c).
constituents in isolates prepared from aged muscles (Picard et al.,
2010) (Figure 4). Collectively, therefore, our data show that the
method used to interrogate mitochondrial function can have a
profound influence on the degree to which mitochondrial function
appears to be altered in aging muscle and that generally speaking,
the degree to which mitochondrial function is altered in aging
muscle is considerably less severe than has often been considered.
This notion is consistent with other studies that have used the
saponin-permeabilized myofibers method, which have found rel-
atively mild (Joseph et al., 2012) or in other cases no impairments
in mitochondrial respiratory capacity in aging muscle (Tonkonogi
et al., 2000; Hutter et al., 2007; Gouspillou et al., 2014b).
Notwithstanding the point about mitochondrial respiratory
alterations in aging muscle being less severe than often considered,
in a follow-up study where we compared indices of mitochondrial
function in saponin-permeabilized myofibers prepared from four
rat muscles that exhibited contrasting fiber type and contrasting
atrophy susceptibility with aging, we did find mitochondrial alter-
ations that we believe bear consideration as a contributing factor
in atrophy of aging muscle (Picard et al., 2011a). Our compari-
son involved two fast twitch muscles [extensor digitorum longus
(EDL), gastrocnemius (Gas)] and two slow twitch muscles [soleus
(Sol), adductor longus (AL)], where the Gas exhibited the most
severe atrophy with aging, the EDL and Sol were similarly affected,
and most strikingly, the AL actually hypertrophied by nearly 50%
and the mitochondrial function was largely preserved in this mus-
cle. Although the factors accounting for this profoundly better
adjustment to aging in the rat AL remain under study, the other
muscles exhibited varying degrees of mitochondrial functional
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alteration with aging. In particular, the Sol was the only muscle
to exhibit a reduction in muscle respiratory capacity (Figure 5A)
and in this case it was secondary to reduced mitochondrial con-
tent. In contrast, although the muscle respiratory capacity was
largely preserved in both of the fast muscles, these two muscles
had higher levels of representative subunits of the mitochon-
drial electron transport complexes, suggesting that the intrinsic
FIGURE 3 | Mechanical isolation (to the left of the vertical line)
markedly exaggerates the apparent impact of aging on skeletal muscle
mitochondria respiratory function, reactive oxygen species (ROS)
emission, and sensitivity to mitochondrial permeability transition pore
(mPTP) opening (permeability transition) compared to
saponin-permeabilized myofibers (to the right of the vertical line).
*P <0.05 versus SEN. Data are re-plotted from Picard et al. (2010).
respiratory capacity of the mitochondrial electron transport sys-
tem was impaired in these fast muscles with aging. Muscle ROS
emission normalized for respiration (an index of the proportion
of O2 consumption lost to ROS leak) demonstrated a general trend
to be elevated in all four muscles under state II and state III condi-
tions, although after normalizing for mitochondrial content only
the Sol demonstrated an increase, suggesting an increase in intrin-
sic mitochondrial ROS emission in aging muscle is not a general
feature of aging muscle (Figure 5A). On the other hand, the sen-
sitivity to permeability transition was increased in the fast twitch
muscles, suggesting greater apoptotic potential. Although we did
not observe a change in this property in the Sol muscle, despite
its marked atrophy with aging, as noted in Section “Addressing
the Question of Mitochondrial Dysfunction in Aging Muscle,” the
time to mitochondrial permeability transition pore (mPTP) open-
ing (permeability transition) in response to a calcium challenge is
typically lower in slow twitch muscle (and higher in fast twitch
muscle). As the aged Sol is characterized by a striking increase
in the fraction of fibers that express fast myosin heavy chain iso-
forms (Edstrom and Ulfhake, 2005; Snow et al., 2005; Carter et al.,
2010), after taking this shift into account, the aged Sol should
have a longer time to mPTP opening than observed, meaning it
too exhibits a sensitization to permeability transition with aging.
This is depicted in Figure 5B as a time to pore (mPTP) open-
ing that falls below the line predicted by the relationship between
time to mPTP opening and percentage of fibers positive for fast
myosin heavy chain. Collectively, therefore, since all three muscles,
which atrophied with aging (EDL, Gas, Sol) exhibited a reduced
time to permeability transition, whereas the only muscle that did
not atrophy (AL) was unaffected, our results reveal that a gen-
eral property of aging muscles undergoing atrophy is an increased
mitochondrial sensitivity to an apoptotic challenge. Taken in con-
text with the abundance of evidence for elevated recruitment of
FIGURE 4 | Hypothesized contamination and/or matrix dilution occurring with the transient rupture of mitochondrial membranes during
mitochondrial isolation procedures. Reproduced with permission from Picard et al. (2011b).
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FIGURE 5 | Impact of aging on mitochondrial function in saponin-
permeabilized myofibers prepared from rat muscles of contrasting
fiber type and atrophy susceptibility is shown. Gas=gastrocnemius
muscle, EDL=extensor digitorum longus muscle, Sol= soleus muscle,
AL= adductor longus muscle. (A) Impact of aging on mitochondrial content,
respiration, and reactive oxygen species (ROS) emission responses.
(B) Sensitivity of mitochondria to permeability transition following a calcium
challenge and how this varies as a function of fast twitch fiber abundance.
Solid black symbols represent the responses of young adult muscles,
whereas the solid red symbols represent responses of senescent muscles.
After taking into account the shift in proportion of fibers positive for fast
myosin heavy chain with aging in each muscle, both the soleus and
gastrocnemius muscles exhibit a sensitization to permeability transition.
Data for mitochondrial content, respiration, ROS, and time to pore opening
are taken from Picard et al. (2011a). Data for proportion of fibers positive for
fast myosin heavy chain are taken from Carter et al. (2010).
mitochondrial-mediated pathways of apoptosis in aging muscle
(Dirks and Leeuwenburgh, 2002; Leeuwenburgh et al., 2005; Siu
et al., 2005; Chabi et al., 2008; Marzetti et al., 2008; Gouspillou et al.,
2014b), this change in mitochondrial function in aging muscle may
be a key to induction of myofiber atrophy.
NON-INVASIVE SPECTROSCOPIC METHODS
The final methodological approach to be discussed in this review
is the use of non-invasive spectroscopic techniques to interrogate
mitochondrial function in aging muscle. Although the value of
these measures is that they provide insights into the function of
the organelle in its native environment, as will be discussed here,
under some circumstances this can pose challenges in deciphering
whether a primary mitochondrial defect exists.
The most common non-invasive spectroscopic approach
for monitoring mitochondrial function in vivo involves
31Phosphorous spectroscopy to determine PCr recovery time
following muscle contractions, as the rate of PCr recovery is
proportional to mitochondrial respiration and content (Mahler,
1985; Meyer, 1988; Prompers et al., 2014). While this is the only
way currently available to gain insights into mitochondrial energy
production in vivo; it is, however, important to note that the rate of
PCr resynthesis following muscle contractions also depends upon
oxygen supply (Haseler et al., 1999). Thus, if muscle blood flow is at
all reduced in aging muscle during the recovery from contractions,
noting that some studies have observed lower blood flow during
dynamic exercise in the elderly (Lawrenson et al., 2003; Poole et al.,
2003), the resulting lower muscle oxygen delivery with aging is a
confounding factor in the interpretation of reduced mitochondrial
energetic capacity in the elderly based upon slower PCr recovery
kinetics alone.
Keeping this point in mind, although several studies report
a reduced rate of PCr recovery following muscle contractions
in aging human gastrocnemius (McCully et al., 1993) and vas-
tus lateralis muscles (Conley et al., 2000), this was not seen in
aging human tibialis anterior muscle of subjects matched for
physical activity levels to the young comparison group (Kent-
Braun and Ng, 2000; Lanza et al., 2005). Although differences
in physical activity status may be part of the explanation for the
different results between studies (Kent-Braun and Ng, 2000), it
may also relate to the aforementioned impact of oxygen delivery
and/or reflect differences in the impact of aging on mitochondr-
ial function in different muscles, as we have shown that occurs
in aged rodents (Picard et al., 2011a) (see Mechanically Isolated
Mitochondria versus Saponin-Permeabilized Myocytes).
Non-invasive spectroscopic methods have also been used to
evaluate mitochondrial coupling in skeletal muscle in vivo. In
particular, several studies have now combined measures of PCr
resynthesis (to derive what has been termed “ATPmax”) with
optical spectroscopic assessment of myoglobin and hemoglobin
oxygen saturations (to derive intramuscular oxygen consump-
tion) to yield a measure of coupling efficiency based upon the
quotient of ATP turnover (derived from the PCr spectroscopy
measures) and oxygen consumption (Amara et al., 2007). These
studies have identified mild uncoupling of mitochondria in both
mouse (Marcinek et al., 2005) and human (Amara et al., 2007)
skeletal muscle. As discussed in the following section, mild uncou-
pling has also been reported in saponin-permeabilized myofibers
from physically active septuagenarian humans (Gouspillou et al.,
2014b). Since uncoupling of mitochondria has been argued as one
strategy for reducing mitochondrial ROS emission and promoting
healthy longevity (Speakman et al., 2004), the mild uncoupling
observed in aged muscle may represent an adaptive response to
keep ROS within physiological levels, rather than a defect per se
(Amara et al., 2007).
MITOCHONDRIAL CONTENT AND FUNCTION IN RELATION
TO AGE AND PHYSICAL ACTIVITY
Amongst the most controversial issues about mitochondrial
impact in aging muscle is that of mitochondrial content. Whilst
some studies have concluded that mitochondrial content is
reduced in aging muscle (Kerner et al., 2001; Chabi et al., 2008),
some find no change (Mathieu-Costello et al., 2005; Callahan
et al., 2014; Gouspillou et al., 2014b; Konopka et al., 2014), and
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others find it to vary between muscles (Lyons et al., 2006; Picard
et al., 2011a). As was the case with measuring mitochondrial
function, many different approaches have been taken to char-
acterize mitochondrial content in aging muscle, including mito-
chondrial marker enzymes (e.g., citrate synthase or cytochrome
oxidase activities), select mitochondrial proteins (e.g., porin, elec-
tron transport system complex subunits), mitochondrial DNA
(mtDNA) copy number, and the gold standard, electron micro-
scopic quantitation of mitochondrial volume density. Although
the wide variety of approaches to inferring mitochondrial content
changes in aging muscle has no doubt contributed to the variability
in interpretation herein, even in studies using the gold standard of
electron microscopy significant variation has been observed. For
example, in two studies examining aged rodent muscle (Mathieu-
Costello et al., 2005) and aged human muscle (Callahan et al.,
2014), there was no change in skeletal muscle mitochondrial con-
tent assessed by electron microscopy with aging, whereas another
study in aged humans did observe a decrease with aging using
the same method and examining the same muscle (vastus lateralis
muscle) (Conley et al., 2000), underscoring the discrepancy on
the question of how aging impacts muscle mitochondrial content.
Amongst the factors that contribute to this variability between
studies, as noted in Section “Addressing the Question of Mito-
chondrial Dysfunction in Aging Muscle,” physical activity levels
can play an important modulating role, where activity-matched
subjects consistently show no decline in indices of mitochondr-
ial content in aging muscle (Lanza et al., 2005; Gouspillou et al.,
2014b). However, whether differences in physical activity status
alone can explain the discordant results remains to be clarified.
Regardless of the controversy about the impact of aging on
mitochondrial content, the capacity for generation of new mito-
chondria declines with aging at ages where the clinical conse-
quences of aging in muscle are most relevant. Specifically, the
ability of aged muscle to augment mitochondrial biogenesis in
response to both endurance exercise training (Betik et al., 2009)
and more severe muscle activity induced by chronic electrical
stimulation (Ljubicic and Hood, 2009; Ljubicic et al., 2009) is
severely compromised in rat muscle from animals at a similar
relative age as humans≥80 years of age. This impairment appears
to be secondary to a failure to upregulate the machinery regulat-
ing mitochondrial biogenesis, including peroxisome proliferator
activated receptor gamma coactivator-1 alpha (PGC-1α) (Betik
et al., 2009), and an accelerated degradation of precursor proteins
destined for import into mitochondria (Huang et al., 2010). To
date, no therapeutic advances have been developed to restore the
mitochondrial biogenesis response in very old muscle, designating
this as an issue of high priority for future investigations.
Coming back to ages where muscle mitochondrial content
remains adaptable (≤80 years of age), not only does physical
activity level modulate mitochondrial content, but it can also
modulate indices of mitochondrial function in aging muscle. In
particular, previous studies have shown that when younger and
older subjects are matched for physical activity levels, there is
no reduction in muscle mitochondrial respiratory capacity with
aging (Kent-Braun and Ng, 2000; Lanza et al., 2005; Safdar et al.,
2010). We recently extended these results to show that, like res-
piratory capacity (Figure 6A), mitochondrial ROS emission is
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FIGURE 6 | Mitochondrial respiration (A), hydrogen peroxide emission
(B), and sensitivity to permeability transition following a calcium
challenge (C) in saponin-permeabilized myofibers prepared from
vastus lateralis muscle biopsies obtained from recreationally active
healthy young (24±1 years; mean±SE) and older (71±2 years) men.
Figures are reproduced with permission from Gouspillou et al. (2014b).
G+M=glutamate+malate; Succ= succinate; AA= antimycin A,
TMPD= artificial electron donor. **P <0.05 versus old.
also not elevated with aging (Figure 6B) when comparing young
adult and septuagenarian subjects with relatively high levels of
recreational physical activity, although as seen in very old rodent
muscle (see Mechanically Isolated Mitochondria versus Saponin-
Permeabilized Myocytes; Picard et al., 2011a), we did observe
a pronounced sensitization of the mitochondria to permeabil-
ity transition (Gouspillou et al., 2014b) (Figure 6C). Indeed,
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the increased apoptotic sensitivity of aged mitochondria was
also accompanied by a marked translocation of a mitochondrial-
derived pro-apoptotic molecule, endonuclease G, to myonuclei in
atrophied septuagenarian human muscle of recreationally active
subjects, suggesting that this may be a key mechanism by which
aged mitochondria contribute to aging muscle atrophy and one
which cannot be circumvented through an active lifestyle (Gous-
pillou et al., 2014b). Potential mechanisms for this will be discussed
in Section “Mechanisms of Primary Defects in Mitochondrial
Function in Aging Muscle.”
MECHANISMS OF PRIMARY DEFECTS IN MITOCHONDRIAL
FUNCTION IN AGING MUSCLE
As noted above, a sensitization of mitochondria to permeability
transition (Picard et al., 2011a) and release of mitochondrial-
derived pro-apoptotic factors (Chabi et al., 2008; Marzetti et al.,
2008) is evident in aged muscle, even in those who remain phys-
ically active (Gouspillou et al., 2014b). In accounting for the rea-
sons for mitochondrial dysfunction in aging muscle, two primary
hypotheses have been put forth to explain declining mitochon-
drial function with aging in general. The first hypothesis relates
to the fact that mitochondria have their own genome, which,
although only encoding for a small fraction of all mitochondr-
ial proteins, is essential for production of normally functioning
mitochondria. Since this genome accumulates damage progres-
sively with aging (Richter et al., 1988; Katayama et al., 1991;
Simonetti et al., 1992; Melov et al., 1995), it is posited that this
leads to impaired synthesis of mitochondria and/or synthesis
of mitochondria with aberrant function (Hiona and Leeuwen-
burgh, 2008). The second hypothesis relates to the fact that
mitochondria must be regularly removed and replaced to pre-
serve their fidelity (Schiavi and Ventura, 2014); it is posited that
this process becomes impaired with aging, resulting in accumu-
lation of damaged mitochondria with aberrant function (Ter-
man et al., 2010; Joseph et al., 2013). The available evidence
relating to these two hypotheses will be discussed in detail
below.
SIGNIFICANCE OF mtDNA MUTATION TO MITOCHONDRIAL
DYSFUNCTION AND AGING MUSCLE ATROPHY
The mtDNA molecule is a small circular genome (approximately
16 k base pairs in length) encoding 37 genes, of which 22 are for
transfer RNAs, 2 are for ribosomal RNAs, and 13 are for polypep-
tide subunits of the respiratory chain and ATP synthase. In this last
respect, the mtDNA encodes for 7 subunits of complex I, 1 subunit
of complex III, 3 subunits of complex IV, and 2 subunits of the
ATP synthase, and these components are essential to normal respi-
ratory function. As evidence of the importance of mtDNA, there
is marked mitochondrial dysfunction in patients with mtDNA
mutations and when these mutations occur in skeletal muscle
they can result in profound exercise intolerance (Taivassalo et al.,
2003). As noted above, mtDNA mutations increase progressively
with increasing age in multiple tissues, including skeletal muscle
(Katayama et al., 1991; Melov et al., 1995; Bua et al., 2006). Further-
more, the focal accumulation of mtDNA mutations to high levels
in skeletal myocytes with aging has been implicated in fiber atro-
phy, breakage, and loss (Lee et al., 1998; Wanagat et al., 2001; Bua
et al., 2002). However, this latter aspect seems to be losing favor for
several reasons. In particular, the proportion of fibers with severe
mitochondrial dysfunction arising from mtDNA mutations is very
low and these fibers do not seem to be consistently smaller than
fibers with healthy mitochondria (Rowan et al., 2011). Further to
this point, the proportion of fibers with focal atrophy at regions
coinciding with high levels of mutant mtDNA and severe elec-
tron transport system dysfunction in human skeletal myocytes is
also too low (in two subjects >65 years of age, only 5% of fibers
with electron transport chain dysfunction exhibited focal atrophy;
Bua et al., 2006) to be biologically meaningful compared to other
causes of atrophy in aging muscle, particularly denervation, which
is the primary cause of myofiber atrophy in very old rat muscle
(Rowan et al., 2012).
Although focal accumulation of mtDNA mutations does not
appear to be a primary cause of skeletal myocyte atrophy with
aging, a mouse engineered with a faulty mtDNA proof-reading
enzyme, the PolG mutant mouse, exhibits a dramatic increase
in rate of mtDNA mutation, a markedly shortened lifespan, and
numerous features that resemble premature aging (Trifunovic
et al., 2004, 2005; Kujoth et al., 2005), including muscle atrophy
(Hiona et al., 2010). Interestingly, the mitochondrial phenotypes
observed in this so-called mtDNA mutator mouse differ in impor-
tant ways from what is seen in normally aging muscle. In particular,
whereas the PolG mutant mouse exhibits reduced levels of mito-
chondrial electron transport system complex subunits in skeletal
muscle, as discussed in Sections“Mechanically Isolated Mitochon-
dria versus Saponin-Permeabilized Myocytes”and“Mitochondrial
Content and Function in Relation to Age and Physical Activity”
this is not a consistent finding in aging rat (Picard et al., 2011a)
or human muscle (Gouspillou et al., 2014b) where levels of mito-
chondrial electron transport system complex subunits are often
higher in aged muscle. Similarly, whereas markers of mitochon-
drial fission and autophagy are higher in the PolG mouse muscle,
normally aged mouse muscle exhibits higher levels of markers of
mitochondrial fusion and lower levels of markers of autophagy
(Joseph et al., 2013). On this basis, mtDNA mutations per se are
unlikely to be the root cause of mitochondrial dysfunction in aging
muscle.
IMPAIRED MITOCHONDRIAL AUTOPHAGY (MITOPHAGY) IN AGING
MUSCLE
As mentioned above, mitochondria normally undergo degra-
dation and replacement to ensure the fidelity of mitochondr-
ial function. Indeed, impairment in mitochondrial autophagy
(mitophagy) is implicated in a wide variety of neudegenerative
disorders (Chu, 2010; Scheibye-Knudsen et al., 2014), in addition
to normal aging (Schiavi and Ventura, 2014). Although in skele-
tal muscle the rate of mitochondrial turnover is unknown (nor
it is understood if it differs between species), mitochondria have
a half-life of approximately 2 days in mouse liver (Miwa et al.,
2008), which when scaled up to the lifespan of an organism means
that mitochondria undergo hundreds to thousands of cycles of
turnover throughout the aging process. Clearly, therefore, if this
rate of renewal were to decline, it seems a likely basis leading to
accumulation of mitochondria with aberrant function in aging
muscle.
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Mitophagy is a tightly regulated process whereby dysfunc-
tional/damaged mitochondria are targeted for removal by incor-
poration into autophagosomes for subsequent degradation by
lysosomes. This targeting of dysfunctional mitochondria for
removal depends upon several mechanisms that are likely rele-
vant for aging. For example, mitophagy is elevated in response to
mitochondrial fragmentation, reduced mitochondrial membrane
potential (e.g., as occurs in mitochondria undergoing perme-
ability transition), and increased mitochondrial ROS emission
(Romanello et al., 2010; Twig and Shirihai, 2011; Schiavi and
Ventura, 2014). Evidence that mitophagy is impaired in aging
muscle is only now beginning to accumulate. Firstly, the fact that
mitochondria with sensitization to permeability transition accu-
mulate in aging muscle (Gouspillou et al., 2014b) is evidence that
mitophagy of damaged mitochondria is impaired since permeabil-
ity transition causes loss of mitochondrial membrane potential,
a potent stimulus for mitophagy (Twig et al., 2008). In addition,
two studies have now shown that Parkin, a mitochondrial-targeted
ubiquitin ligase, which interacts with the autophagy protein LC3 to
induce formation of autophagosomes around dysfunctional mito-
chondria, is reduced in skeletal muscle of both physically active
septuagenarian men (Gouspillou et al., 2014b) and in physically
inactive frail older women (Drummond et al., 2014). Furthermore,
impairments in the signaling pathway that regulates mitochondr-
ial quality control have also been reported in aging mouse muscle
(Joseph et al., 2013) and aging human muscle (Koltai et al., 2012).
Thus, whereas the significance of mtDNA mutations in mitochon-
drial dysfunction in aging muscle is less clear, impaired mitophagy
appears a likely contributor to accumulation of dysfunctional
mitochondria in aging muscle. Importantly, that this appears to
also occur in physically active subjects (Gouspillou et al., 2014b)
underscores that new therapeutic approaches will be required to
address this problem.
Although their particular role in aging remains to be estab-
lished, two promising new targets involved in regulating degrada-
tion of damaged mitochondria are the micro RNA miR137 and the
AAA ATPase p97. miR137 has been identified to inhibit mitophagy
occurring in response to hypoxia, through reducing the interaction
of LC3 with two mitophagy receptors, FUNDC1 and NIX (Li et al.,
2014). p97 is specifically involved in targeting and removal of car-
bonylated mitochondrial proteins for subsequent degradation by
the ubiquitin proteasome (Hemion et al., 2014). If these pathways
are disrupted in aging muscle, they are likely targets for improving
removal of damaged mitochondria and thus, ameliorating aging
impact.
EXTRINSIC FACTORS THAT COULD MODULATE
MITOCHONDRIAL FUNCTION IN AGING MUSCLE
Although mitochondrial changes in aging muscle are most often
considered as primary dysfunction suitable for therapeutic target-
ing, this view does not consider the influence of factors extrinsic to
the mitochondrion that constitute the aging intracellular milieu.
For example, age-related changes in the intracellular milieu could
depress certain aspects of mitochondrial function independent
of the intrinsic mitochondrial functional capacity per se and
recent data support this idea. In addition, other changes impacting
aging muscle, such as impaired neuromuscular junction stability
and myofiber denervation, could also modulate mitochondrial
function as a secondary consequence.
In addressing the potential involvement of the aging milieu as
an inhibitory influence on mitochondrial function in aging mus-
cle, Siegel et al. (2013) recently characterized mitochondrial func-
tion in vivo in distal hindlimb muscles of young (5 months old)
and aged (27 months old) mice using optical and 31Phosphorous
magnetic resonance spectroscopy, finding a decrease in mitochon-
drial respiratory function (reduced maximal ATP production rate,
reduced coupling, and reduced rate of PCr resynthesis). Strik-
ingly, these age-related impairments in mitochondrial respiratory
function were restored to youthful levels 1 h following the admin-
istration of a mitochondria-specific antioxidant peptide, SS-31
(Figures 7A–E), and this was also accompanied by an increased
muscle fatigue resistance and running time to exhaustion in
the aged mice but not younger mice. In stark contrast to these
acute in vivo results, when mitochondrial respiratory function
was examined in saponin-permeabilized myofibers there was no
detectable impairment in mitochondrial respiratory function with
aging and administration of SS-31 had no effect (Figures 7F,G),
despite inducing a reduction in mitochondrial ROS emission. The
implications of these results is that, independent of the intrinsic
function of the organelle, mitochondrial function can be impeded
in vivo by oxidative stress in the intracellular environment of aging
muscle. Thus, these recent findings underscore the importance of
considering aspects of the aging milieu as contributing factors to
impairing mitochondrial function in vivo, and demand further
study of how this may affect other aspects of mitochondrial func-
tion (e.g., ROS emission, sensitivity to permeability transition)
with aging. Furthermore, these results also show that manipula-
tion of the aging milieu, rather than the mitochondrion directly,
can be an effective strategy for improving mitochondrial function
in aging muscle.
As noted in the section “Introduction,” mitochondria serve as
cellular rheostats that integrate a wide variety of intracellular sig-
nals and modify aspects of their function as appropriate to those
cellular conditions. Although intrinsic impairment in mitochon-
drial function involving an increased sensitivity to permeability
transition in mitochondria from aged muscle has been demon-
strated in both a sedentary rat model (Picard et al., 2011a) and in
physically active aging humans (Gouspillou et al., 2014b), whether
factors upstream of the mitochondrion can also modulate mito-
chondrial function is unclear. This question may be particularly
relevant when aging muscle atrophy becomes severe and more
likely to yield clinical impact because it is likely that additional
mechanisms come into play in driving an acceleration of muscle
atrophy. In this respect, as noted from the outset of this review,
the age at which aging muscle atrophy is most likely to cause
clinical consequences such as an increased risk of falls and phys-
ical frailty, is in individuals ≥80 years of age (Cruz-Jentoft et al.,
2010). Significantly, in an aging rat model this corresponds to a
period where muscle atrophy accelerates through the accumula-
tion of small angular fibers characteristic of long-term denervation
(Rowan et al., 2011).
Although evidence of an accumulation of denervated myofibers
in skeletal muscle at very advanced age in humans thus far is based
only upon the morphological appearance of small angular fibers
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FIGURE 7 | Influence of the aging intracellular milieu on mitochondrial
function in vivo in mouse skeletal muscle. (A) P/O ratio, (B) in vivo ATPase
rate; (C) in vivo rate of oxygen consumption; (D) in vivo rate of
phosphocreatine (PCr) resynthesis following muscle contractions; (E) in vivo
maximal rate of ATP synthesis (ATPmax); (F) state 4 respiration in
saponin-permeabilized myofibers; (G) state 3 respiration in
saponin-permeabilized myofibers. Figures are reproduced with permission
from Siegel et al. (2013).
(Scelsi et al., 1980) that are typical of neuropathologies such as
amyotrophic lateral sclerosis and polyneurophathy (Baloh et al.,
2007), the presence of denervated myofibers in very old mouse
(Wang et al., 2005) and rat muscle (Rowan et al., 2012) has been
confirmed by probing in situ for a sodium channel isoform typ-
ical of denervation in adult muscle, NAV1.5 (Kallen et al., 1990;
Yang et al., 1991). Importantly, these denervated myofibers also
demonstrate a marked up-regulation of the ubiquitin ligases mus-
cle atrophy F-box (MAFbx) and muscle ring finger 1 (MuRF1)
(Rowan et al., 2012), and the up-regulation of these proteins in
response to denervation is dependent upon release of mitochon-
drial lipid hydroperoxides that can be detected in some ROS assays
(Bhattacharya et al., 2009). Thus, denervation can also recruit
mitochondrial-mediated proteolytic pathways, raising the likeli-
hood that at least some of the alterations in mitochondria seen in
skeletal muscle at very advanced age are a secondary event to den-
ervation rather than a primary organelle defect. A schematic repre-
sentation of how we hypothesize that denervation may modulate
mitochondrial pathways of atrophy in aging muscle is provided
in Figure 8. Since understanding this issue is key to advancing to
new therapeutic targets, future study of how sporadic denervation
may modulate mitochondrial function across the continuum of
aging muscle atrophy is clearly warranted to better define when
intervening at the level of the mitochondrion is most appropriate.
CONCLUSION
Our understanding of the impact of aging on mitochondrial func-
tion in aging skeletal muscle continues to evolve and has recently
undergone significant revision. In particular, it now appears that
mitochondrial functional alterations are more subtle than initially
indicated, owing to an exaggeration of mitochondrial impact with
aging when using isolated organelles (a common approach in
early studies). Furthermore, whereas mitochondrial respiratory
function and ROS emission changes are highly variable between
muscles and are also largely attenuated by maintaining physical
activity, a sensitization of the mitochondria to permeability tran-
sition seems to be a general property of aging muscles undergoing
atrophy regardless of physical activity status. The mechanisms
contributing to this mitochondrial functional alteration in aging
muscle remains an area of intensive study. Presently, it seems that
mtDNA-driven mechanisms are incompatible with the available
evidence and instead impairment in mitophagy is appearing the
more likely culprit based upon data from recent studies show-
ing alterations in mitophagy signaling. In this respect, there is
also emerging evidence that the aging milieu can itself depress
mitochondrial respiratory function in vivo, even in the absence
of an intrinsic organelle defect in mitochondria studied ex vivo.
Furthermore, the likelihood that other extrinsic factors, such as
denervation, may also be modulating mitochondrial function at
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FIGURE 8 | Schematic representation of the mitochondrial-mediated
atrophy pathways that have been observed to be up-regulated in
aging muscle and their hypothesized link to the upstream influence of
sporadic denervation in very advanced age where denervation
becomes pronounced. BAX=Bcl2-associated X protein,
PLA2= cytoplasmic phospholipase A2, AIF= apoptosis inducing factor;
EndoG= endonuclease G, p-AMPK=phosphorylated adenosine
monophosphate kinase, FoxO3= forkhead box O3,
BNIP3=BCl2/adenovirus E1B 19 kDa protein-interacting protein 3,
LC3=microtubule associated protein light chain 3, MAFbx=muscle
atrophy F-box, MuRF1=muscle ring finger 1.
very advanced and clinically relevant ages requires careful con-
sideration of the most appropriate ages at which to target the
mitochondrion in seeking more effective treatments for aging
muscle. Based on current evidence, it is suggested that an increased
susceptibility to permeability transition at ages preceding the most
severe clinical impact of aging muscle atrophy (≤75 years) is an
appropriate therapeutic target and should be pursued. However,
at clinically relevant ages where an increased falls risk, mobility
impairment, and physical frailty are more likely to result from
aging muscle impact, it remains to be determined whether mito-
chondrial alterations are now largely secondary to denervation,
rendering the mitochondrion a less attractive therapeutic target
for the ≥ 80 years age group.
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